EP1576169A4
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
84 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55 Sheet 56 Sheet 57 Sheet 58 Sheet 59 Sheet 60 Sheet 61 Sheet 62 Sheet 63 Sheet 64 Sheet 65 Sheet 66 Sheet 67 Sheet 68 Sheet 69 Sheet 70 Sheet 71 Sheet 72 Sheet 73 Sheet 74 Sheet 75 Sheet 76 Sheet 77 Sheet 78 Sheet 79 Sheet 80 Sheet 81 Sheet 82 Sheet 83 Sheet 84
Every citation, both waysCites: the store holds 12 of 13
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO02081517A2 | Cites | World Intellectual Property Organization (WIPO) | PX | Search report | 1-34 |
| WO02098920A1 | Cites | World Intellectual Property Organization (WIPO) | PX | Search report | 1-34 |
| WO03002722A2 | Cites | World Intellectual Property Organization (WIPO) | PX | Search report | 1-34 |
| WO03003906A2 | Cites | World Intellectual Property Organization (WIPO) | PX | Search report | 1-34 |
| WO03025138A2 | Cites | World Intellectual Property Organization (WIPO) | E | Search report | 1-34 |
| WO03042661A2 | Cites | World Intellectual Property Organization (WIPO) | E | Search report | 1-34 |
| WO03002722A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO03003906A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO02081517A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO02098920A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO03025138A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO03042661A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| FEIGELSTOCK D ET AL: "The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 72, no. 8, 1 August 1998 (1998-08-01), pages 6621 - 6628, XP002959127, ISSN: 0022-538X | Non-patent | – | – | Search report | – |
940 members in 18 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 365491P | United States of America | – | |
| 36549102 | United States of America | P | |
| 36549102 | United States of America | P | |
| 410618P | United States of America | – | |
| 41061802 | United States of America | P | |
| 41061802 | United States of America | P | |
| 0308490 | United States of America | W | |
| 0308490 | United States of America | W | |
| 365491P | – | – | – |
| 410618P | – | – | – |
| US20020365491P | – | – | – |
| US20020410618P | – | – | – |
| US2003008490 | – | – | – |
| WO2003US08490 | – | – | – |
Members940
| Document | Office | Kind | |
|---|---|---|---|
| CA2347120A1 | Canada | A1 | |
| WO0020448A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6293799A | Australia | A | |
| CA2362422A1 | Canada | A1 | |
| WO0053742A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3736000A | Australia | A | |
| CA2365910A1 | Canada | A1 | |
| WO0061754A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4216800A | Australia | A | |
| WO0020448A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2374053A1 | Canada | A1 | |
| WO0070046A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5134200A | Australia | A | |
| CA2375424A1 | Canada | A1 | |
| WO0075321A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5726200A | Australia | A | |
| CA2377263A1 | Canada | A1 | |
| WO0078802A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5634700A | Australia | A | |
| CA2379925A1 | Canada | A1 | |
| WO0105971A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0053742A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU6229100A | Australia | A | |
| CA2381396A1 | Canada | A1 | |
| WO0110902A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6899700A | Australia | A | |
| CA2384749A1 | Canada | A1 | |
| WO0119856A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0123561A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CA2386199A1 | Canada | A1 | |
| CA2386383A1 | Canada | A1 | |
| WO0125436A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0125437A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7377300A | Australia | A | |
| CA2385196A1 | Canada | A1 | |
| CA2386925A1 | Canada | A1 | |
| WO0127277A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0127290A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1202101A | Australia | A | |
| AU8023100A | Australia | A | |
| CA2386922A1 | Canada | A1 | |
| WO0129217A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1204301A | Australia | A | |
| AU7717800A | Australia | A | |
| WO0078802A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU1631701A | Australia | A | |
| AU7868000A | Australia | A | |
| CA2391885A1 | Canada | A1 | |
| WO0136638A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1616801A | Australia | A | |
| WO0061754A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2392110A1 | Canada | A1 | |
| WO0110902A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0140291A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1817201A | Australia | A | |
| WO0123561A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2395212A1 | Canada | A1 | |
| WO0146231A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2287101A | Australia | A | |
| WO0070046A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0075321A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0151632A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2792501A | Australia | A | |
| WO0110902A8 | World Intellectual Property Organization (WIPO) | A8 | |
| EP1119619A2 | European Patent Office (EPO) | A2 | |
| WO0070046A9 | World Intellectual Property Organization (WIPO) | A9 | |
| WO0159113A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3975601A | Australia | A | |
| CA2400332A1 | Canada | A1 | |
| CA2400360A1 | Canada | A1 | |
| WO0161008A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0161009A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3830301A | Australia | A | |
| AU4149001A | Australia | A | |
| WO0162928A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3988901A | Australia | A | |
| WO0166747A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CA2401552A1 | Canada | A1 | |
| AU4729401A | Australia | A | |
| WO0105971A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2374073A1 | Canada | A1 | |
| WO0170978A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4592001A | Australia | A | |
| WO0136638A8 | World Intellectual Property Organization (WIPO) | A8 | |
| CA2404519A1 | Canada | A1 | |
| CA2404541A1 | Canada | A1 | |
| WO0174856A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0174904A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5124701A | Australia | A | |
| WO0105971A9 | World Intellectual Property Organization (WIPO) | A9 | |
| CA2406096A1 | Canada | A1 | |
| WO0179294A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0179563A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5909601A | Australia | A | |
| AU5910901A | Australia | A | |
| EP1159417A2 | European Patent Office (EPO) | A2 | |
| CA2412256A1 | Canada | A1 | |
| WO0140291A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0200691A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7021501A | Australia | A |
Showing 100 of 940
79 legal events, as 8 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Patent invalid in the netherlands as no translation has been filedMP | MP | NL | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Reference to at number (ep patent enters austrian national phase)REF | REF | AT | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Intention to grant announcedINTG | INTG | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: C12Q0001000000R079 | R079 | DE | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Availability of information related to the publication of the international search reportORIGINAL CODE: 0009015PUAK | PUAK | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1576169
- Publication, DOCDB
- 1576169
- Publication, EPODOC
- EP1576169
- Application
- 3726083
- Application, DOCDB
- 03726083
- Application, EPODOC
- EP20030726083
Titles3
- German
- THERAPEUTISCHE POLYPEPTIDE, DIESE CODIERENDE NUKLEINSÄUREN UND VERWENDUNGSVERFAHREN
- English
- THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE
- French
- POLYPEPTIDES THERAPEUTIQUES, ACIDES NUCLEIQUES CODANT POUR CEUX-CI ET METHODES D'UTILISATION ASSOCIEES
Classification
- CPC, 5
- C07K14/47
- G01N33/6893
- G01N2800/042
- A61P29/00
- A61P35/00
- IPC, 29
- A61K38 00
- A61K38 17
- A61K39 395
- A61P29 00
- A61P35 00
- C07K14 47
- C07K16 18
- C07K19 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N5 10
- G01N33 50
- C12N15 09
- C12P21 02
- C12P21 08
- C12Q1 02
- C12Q1 68
- G01N33 15
- G01N33 53
- G01N33 567
- G01N33 68
- C07H21 02
- C07H21 04
- C07K14 00
- C07K16 00
- C12N15 63
- C12P21 06
- G01N33 00
Designated states1
- Contracting states, 1
- Türkiye
